Effect of choline on central dopaminergic function in normal subjects

Area of Science:

• Neuroendocrinology
• Pharmacology
• Human Physiology

Background:

• Cholinergic and dopaminergic systems interact within the central nervous system.
• The precise role of cholinergic mechanisms in regulating hypothalamic-pituitary hormones requires further elucidation.
• Previous research suggests differing effects of cholinergic activity on dopaminergic function in various brain regions.

Purpose of the Study:

• To investigate the effect of oral choline administration on basal serum concentrations of growth hormone and prolactin in normal subjects.
• To determine if choline influences growth hormone secretion stimulated by apomorphine hydrochloride.
• To explore the potential role of cholinergic pathways in modulating hypothalamic-pituitary dopaminergic function in humans.

Main Methods:

• A study involving 5 healthy normal subjects.
• Oral administration of 10 g of choline.
• Measurement of basal serum growth hormone and prolactin levels.
• Assessment of growth hormone secretion following subcutaneous injection of apomorphine HCl (0.5 mg) with and without prior choline administration.

Main Results:

• Oral choline (10 g) did not significantly affect basal serum growth hormone or prolactin concentrations.
• Choline administration significantly potentiated the increase in growth hormone secretion induced by apomorphine HCl.
• No significant effects were observed on basal prolactin levels.

Conclusions:

• Cholinergic mechanisms, as modulated by choline, may play a role in enhancing hypothalamic-pituitary dopaminergic function in humans.
• These findings contrast with the known inhibitory effects of cholinergic pathways on dopaminergic function in the basal ganglia.
• Choline's ability to enhance apomorphine-induced growth hormone release suggests a specific facilitatory role in the neuroendocrine axis.